Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI PET/MR for Intracranial and Carotid Atherosclerosis
NCT05036759Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-FAPI in atherosclerosis, sponsored by Peking Union Medical College Hospital. Primary endpoint: Diagnostic performance at 2 years. Status: unknown.
02
Drugs
68Ga-FAPI
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT05036759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05036759.